Inflammation and arrhythmias: Potential mechanisms and clinical implications

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 9, 2014, Pages 1077-1085

  Lewek, Joanna ^a   Kaczmarek, Krzysztof ^a   Cygankiewicz, Iwona ^a   Wranicz, Jerzy K ^a   Ptaszynski, Pawel ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

atrial arrhythmia; biomarkers; inflammation; myocarditis; pericarditis; ventricular arrhythmia

Indexed keywords

BIOLOGICAL MARKER;

CHRONIC INFLAMMATION; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFLAMMATION; REVIEW; ACUTE DISEASE; ANIMAL; ARRHYTHMIAS, CARDIAC; CHRONIC DISEASE; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY;

ACUTE DISEASE; ANIMALS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CHRONIC DISEASE; HUMANS; INFLAMMATION;

EID: 84906734990     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.942286     Document Type: Review

References (90)

1. Biomarkers Definitions Working Group. Biomarkers and surrogates endpoints: Preffered definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89
2. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease. application to clinical and public health practice. a statement for healthcare professionals from the Centers for Disease Control and Prevention and American Heart Association. Circulation 2003;107:499-511
3. Libby P, Ridker PM. Inflammation and atherothrombosis: From population biology to bench research to clinical practice. J Am Coll Cardiol 2006;48:33-46
4. Verma S, Szmitko PE, Yeh ET. C-reactive protein. Structure affects function. Circulation 2004;109:1914-17
5. Pasquié JL, Sanders P, Hocini M, et al. Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts. J Cardiovasc Electrophysiol 2004;15:1-6
6. Pasquié JL. May fever trigger ventricular fibrillation?. Indian Pacing Electrophysiol J 2005;5:139-45
7. Müller D, Agrawal R, Hans-Richard A. How sudden is sudden cardiac death?. Circulation 2006;114:1146-50
8. Fabre A, Sheppard MN. Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart 2006;92:316-20
9. D'Aloia A, Faggiano P, Brentana L, et al. Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm. Int J Cardiol 2005;103:207-8
10. Dinckal MH, Davutoglu V, Akdemir I, et al. Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: Fatal electrical storm. Europace 2003;5:257-61
11. Patruno N, Pontillo D, Achilli A, et al. Electrocardiographic pattern of Brugada syndrome disclosed by a febrile illness: Clinical and therapeutic implications. Europace 2003;5:251-5
12. Magnani JW, Dec GW. Myocarditis: Current Trends in Diagnosis and Treatment. Circulation 2006;113:876-90
13. Oakley CM. Myocarditis, pericarditis and other pericardial diseases. Heart 2000;84: 449-54
14. Baddour LM, Wilson WR, Bayer AS, et al AHA Scientific Statement Infective endocarditis Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: Endorsed by the infectious diseases society of America. Circulation 2005;111:394-434
15. Ristic A, Maisch B, Hufangel G, et al. Arrhythmia in acute pericarditis. An endomyocardial biopsy. Herz 2000;25: 729-33
16. Imazio M, Cechi E, Demichemis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008;94:498-501
17. Arbustini E, Porcu E, Grasso M, et al. Enteroviral infection causing fatal myocarditis and subclinical myopathy. Heart 2000;83:86-90
18. Rosenfeld ME, Beckerman B, Ward MF, Sama A. Lyme carditis: Complete AV dissociation with episodic asystole presenting as syncope in the emergency department. J Emerg Med 1999;17:661-4
19. Gasser R, Lercher P, Klein W. Lyme carditis and borrelia-Associated dilated cardiomyopathy. Heart Fail Rev 1999;3: 241-8
20. Ciesielsky CA, Markowitz LE, Horsley R. Lyme disease surveillance in the United States: 1983-86. Rev Infect Dis 1989(Suppl 6):1425-41
21. Coura JR. Chagas disease: What is known and what is needed. A background article. Mem Inst Oswaldo Cruz 2007;102:113-22
22. Terasaki F, Kitaura Y, Nakayama Y, et al. Arrhythmias in Coxsackie B3 virus myocarditis. Continuous electrocardiography in conscious mice and histopathology of the heart with special reference to the conduction system. Heart Vessels Suppl 1990;5:45-50
23. Hoshino T, Matsumori A, Kawai C, Imai J. Ventricular aneurysm and ventricular arrhythmias complicating Coxsackie virus B1 myocarditis of Syrian golden hamster. Cardiovasc Res 1984;18:24-9
24. Klein RM, Vester EG, Brehm MU, et al. Inflammation of the myocardium as arrhythmia trigger. Z Kardiol 2000;89: 24-35
25. Saito J, Niwano S, Niwano H, et al. Electrical remodeling of the ventricular myocardium in myocarditis. Circ J 2002;66: 97-103
26. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 2007;4:1-46
27. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. J Am Coll Cardiol 1976;235:39-41
28. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA. American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128:9S-16S.
29. Materazzo C, Piotti P, Mantovani C, et al. Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment. Eur J Cardiothorac Surg 2007;31:812-16
30. Amar D. Postthoracotomy atrial fibrillation. Curr Opin Anaesthesiol 2007;20:43-7
31. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85: 766-82
32. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997;112: 676-92
33. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8
34. Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005;111:2881-8
35. Mathew JP, Fontes ML, Tudor IC, et al. Multicenter risk index for atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2004;291:1720-9
36. Lamm G, Auer J, Weber T, et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006;20:51-6
37. Amar D, Goenka A, Zhang H, et al. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann Thorac Surg 2006;82:1057-61
38. Prasongsukarn K, Abel JG, Jamieson E, et al. The effect of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial. J Thorac Cardiovasc Surg 2005;130:93-8
39. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. J Am Coll Cardiol 2007;297:1562-7
40. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysarhythmia After cardiac surgery) study. Circulation 2006;114:1455-61
41. Ahlsson AJ, Bodin L, Lundblad OH, Englund AG. Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg 2007;83:1332-7
42. Hogue CW Jr, Palin CA, Kailasam R, et al. C-reactive protein levels and atrial fibrillation after cardiac surgery in women. Ann Thorac Surg 2006;82:97-102
43. Lopshire JC, Zipes DP. Sudden cardiac death. better understanding of risks, mechanisms and treatment. Circulation 2006;114:1134-6
44. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL; Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002;39:632-7
45. Blangy H, Sadoul N, Dousset B, et al. Serum BNP, hs-CRP, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 2007;9:724-9
46. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations and management. Postgrad Med J 2001;77:4-11
47. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 1999;99: 1091-100
48. Zimmermann O, Kochs M, Zwaka TP, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 2005;104: 92-100
49. Noutsias M, Pauschinger M, Schultheiss HP , Kühl U. Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J Suppl 4:I54-62
50. Tomaselli GF, Zipes DP. What causes sudden cardiac death in heart failure. Circ Res 2004;95:754-63
51. Doughan AR, Williams BR. Cardiac Sarcoidosis. Heart 2000;92:282-8
52. Roberts WC, McAlister HA, Ferrons VJ. Sarcoidosis of the heart. Am J Med 1977;63:86-108
53. Mendoza I, Moleiro F, Marques J, et al Implications of sudden death in Chagas disease revista De patologia tropical. 1997;26:155-61
54. Mendoza I, Moleiro F, Marques J. Morte súbita na doença De Chagas. Arq Bras Cardiol 1992;59:3-4
55. Rassi A, Rassi A, Little W, et al. Development and validation of a risk score for predicting death in chagas' heart disease. N Engl J Med 2006;356:355-8
56. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9
57. Barbarini G, Barbaro G. Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 2003;17:S46-50
58. Albert CM, Ma J, Rafai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002;105:2595-9
59. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4
60. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80
61. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91
62. Maixent JM, Paganelli F, Scaglione J, Levy S. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:612-17
63. Cheng T, Wang XF, Hou YT, Zhang L. Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines. Mol Med Rep 2012;6:581-4
64. Prage P, Hisham D, Peter T, Nasser L. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:1064-70
65. Sata N, Hamada N, Horinouchi T, et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 2004;45: 441-5
66. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004;25: 1100-7
67. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-3010
68. Hanna IR, Heeke B, Bush H, et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 2006;8:881-6
69. Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003;92:1379-83
70. Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005;149: 548-57
71. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol 2005;45:712-19
72. Swedberg K, Cohen-Solal A, Granger C, et al. Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: Results from the CHARM study. J Am Coll Cardiol 2004;23:222A.
73. Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies of Left Ventricular Dysfunction (SOLVD) Trials. Circulation 2003;107:2926-31
74. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-73
75. Frost L, Vestergaard P. n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: The Danish diet, cancer, and health study. Am J Clin Nutr 2005;81:50-4
76. Korantzopoulos P, Kolettis TM, Kountouris E, et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 2005;102:321-6
77. Rotter M, Jaïs P, Vergnes MC, et al. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2006;47: 1231-3
78. Marcus GM, Smith LM, Glidden DV, et al. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm 2008;5:215-21
79. Kallergis EM, Manios EG, Kanoupakis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart 2008;94:200-4
80. Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med 1999;340: 449-54
81. Guo Y, Lip GY, Stavaros A. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60(22):2263-70
82. Kaski JC, Arrebola-Moreno AL. Inflammation and thrombosis in atrial fibrillation. Rev Esp Cardiol 2011;64:551-3
83. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 2008;51:1790-3
84. Patruno N, Pontillo D, Achilli A, et al. Electrocardiographic pattern of Brugada syndrome disclosed by a febrile illness: Clinical and therapeutic implications. Europace 2003;5:251-5
85. Tai YT, Lau CP, Fong PC, et al. Incessant ventricular tachycardia complicating acute Coxsackie B myocarditis. Cardiology 1992;82:339-44
86. Hosenpud JD, McAnulty JH, Nelson RN. Unexpected myocardial disease in patient with life threatening arrhythmias. BMJ 1986;56:55-61
87. Mehe I, Lacroix D, Kouakam C, Kacet S. Ventricular tachycardia revealing viral myocarditis. Presse Med 1998;27:1947-50
88. Wiles HB, Gillete PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J Am Coll Cardiol 1992;20:359-62
89. Turgeman Y, Antonelli D, Rosenfeld T. Polymorphous ventricular tachyarrhythmia in acute myocarditis. Harefuah 1990;119: 7-8
90. Conway DS, Buggins P, Hughes E, Lip GY. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 2004;43:2075-82.